Skip to main content
AS

AIDO sas

AIDO develops an intelligent, modular assistant system compatible with existing endoscopes to enhance practitioner performance during complex endoscopic procedures. This technology facilitates non-invasive treatment and standardized biopsy collection for digestive and pancreatic cancers. The system aims to improve early diagnosis and patient outcomes while optimizing resource utilization in endoscopy.

Strasbourg, FranceFounded 2022150+ followers
Updated 3 months ago

Funding

$9.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Endoscopic procedures, particularly biopsies of the pancreas and early treatment of colorectal cancer, are complex and require a high degree of manual precision, which can be challenging for physicians and limit patient access to minimally invasive treatments. The difficulty in standardizing these procedures can lead to variability in diagnostic accuracy and treatment outcomes, especially when targeting small lesions.

Solution

AIDO is developing a robotic add-on for standard endoscopes that acts as an intelligent assistant, enhancing the endoscopist's control and precision during interventional procedures. The system comprises modular hardware and software components designed to facilitate and standardize complex biopsies, particularly in the pancreas, to improve early cancer detection. By improving the capacity of current endoscopes, AIDO aims to facilitate patient access to non-invasive, best-in-class treatment with limited resources. The technology is designed for intuitive use, easing adoption without extensive training.

Target Audience

The primary target audience includes endoscopists and medical professionals specializing in gastroenterology and interventional endoscopy, particularly those focused on pancreatic and colorectal cancer diagnostics and treatment.

Features

  • Robotic add-on compatible with existing endoscopes
  • Modular hardware and software design for seamless integration
  • Enhanced control and precision for complex endoscopic procedures
  • Facilitates and standardizes biopsies of small lesions in the pancreas
  • Aims to improve early cancer detection and treatment
  • Designed for intuitive use, minimizing the need for extensive training
This profile is AI-generated and may contain inaccuracies.